Katherine Rogers, LPN | |
1348 Wyndham Ln, Carthage, MO 64836-7480 | |
(417) 388-9877 | |
Not Available |
Full Name | Katherine Rogers |
---|---|
Gender | Female |
Speciality | Licensed Practical Nurse |
Location | 1348 Wyndham Ln, Carthage, Missouri |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1396339297 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
164W00000X | Licensed Practical Nurse | 2006024423 (Missouri) | Primary |
Mailing Address | Practice Location Address |
---|---|
Katherine Rogers, LPN 1348 Wyndham Ln, Carthage, MO 64836-7480 Ph: (417) 388-9877 | Katherine Rogers, LPN 1348 Wyndham Ln, Carthage, MO 64836-7480 Ph: (417) 388-9877 |
News Archive
Scientists have called it "junk DNA." They have long been perplexed by these extensive strands of genetic material that dominate the genome but seem to lack specific functions. Why would nature force the genome to carry so much excess baggage?
House Republican lawmakers are questioning hiring practices at the Department of Health and Human Services as well as how the Internal Revenue Service will enforce provisions of the health law.
While in Germany, Partho P. Sengupta, MD, of Icahn School of Medicine at Mount Sinai used a computer to perform a robot-assisted trans-Atlantic ultrasound examination on a person in Boston.
Health-overhaul legislation signed into law this week will affect not only America's health care industry, but the broader economy, too, The Christian Science Monitor reports. The overhaul could help create jobs. "But the legislation also means tax hikes, mainly on the highest-income Americans. And provisions designed to curb healthcare costs probably aren't strong enough to put a big dent in medical inflation - or federal budget deficits" (Trumbull, 3/24).
Pro-Pharmaceuticals, Inc., a developer of therapeutics that target Galectin receptors to treat cancer and fibrosis, today announced it has been notified that it has been awarded approximately $489,000 total in two federal grants under the Qualifying Therapeutic Discovery Project ("QTDP") Program.
› Verified 4 days ago